About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study In Patients With Type 2 Diabetes Mellitus

A Study In Patients With Type 2 Diabetes Mellitus

NCT00256867·85 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

A clinical diagnosis type 2 diabetes mellitus.
Women must not be pregnant or breastfeeding during the study and 30 days after the study.
Must sign an informed consent form at the study clinic.

You may not be if

Severe chronic diseases that would prevent from participating and completing the study by investigator's judgement.
Use of an investigational drug within 30 days or 5 half lives before first dose of study medication.
Insulin use for \> 1 week in past 3 months.

The record

StatusCompleted

PhasePhase 3

Taking part369

StartedAug 2005

UpdatedJul 2, 2018

Conditions

Diabetes Mellitus, Type 2

Where85

GSK Investigational Site
Tucson, Arizona, United States
GSK Investigational Site
Fresno, California, United States
GSK Investigational Site
Wheat Ridge, Colorado, United States